Neurocrine Bioscience buy Morgan Stanley
Start price
12.07.24
/
50%
€136.55
Target price
12.07.25
€155.89
Performance (%)
-17.17%
End price
13.07.25
€113.10
Summary
This prediction ended on 13.07.25 with a price of €113.10. The prediction for Neurocrine Bioscience disappointed with a performance of -17.17%. Morgan_Stanley has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -4.600% | -4.600% | -17.754% |
| iShares Core DAX® | -1.351% | 0.610% | 37.046% |
| iShares Nasdaq 100 | -1.453% | 3.019% | 22.196% |
| iShares Nikkei 225® | -0.021% | 1.195% | 12.929% |
| iShares S&P 500 | -1.326% | 2.830% | 16.099% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $160.00 to $170.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.00
04.02.25
04.02.25
€178.90
04.02.26
04.02.26
-25.03%
08:00
08:00
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€138.22
31.07.26
31.07.26
-1.96%
08:00
08:00
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.50
22.07.25
22.07.25
€128.31
22.07.26
22.07.26
-1.91%
08:00
08:00
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.00
07.03.25
07.03.25
€138.30
07.03.26
07.03.26
5.67%
08:00
08:00
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25